Cargando…

Electroceuticals in medicine – The brave new future

Electroceuticals are a new category of therapeutic agents which act by targeting the neural circuits of organs. The therapy involves mapping the neural circuitry and delivering neural impulses to these specific targets. The impulse is administered via an implantable device. In cardiology besides pac...

Descripción completa

Detalles Bibliográficos
Autor principal: Mishra, Sundeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650563/
https://www.ncbi.nlm.nih.gov/pubmed/29054204
http://dx.doi.org/10.1016/j.ihj.2017.10.001
_version_ 1783272723837878272
author Mishra, Sundeep
author_facet Mishra, Sundeep
author_sort Mishra, Sundeep
collection PubMed
description Electroceuticals are a new category of therapeutic agents which act by targeting the neural circuits of organs. The therapy involves mapping the neural circuitry and delivering neural impulses to these specific targets. The impulse is administered via an implantable device. In cardiology besides pacemaker, defibrillation and resynchronization applications it could have usefulness in heart failure, atrial fibrillation, coronary artery disease, myocarditis, resistant hypertension, atrial and ventricular tachyarrhythmias, pulseless electrical activity, and refractory angina.
format Online
Article
Text
id pubmed-5650563
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-56505632018-09-01 Electroceuticals in medicine – The brave new future Mishra, Sundeep Indian Heart J Le Voyageur Temp Electroceuticals are a new category of therapeutic agents which act by targeting the neural circuits of organs. The therapy involves mapping the neural circuitry and delivering neural impulses to these specific targets. The impulse is administered via an implantable device. In cardiology besides pacemaker, defibrillation and resynchronization applications it could have usefulness in heart failure, atrial fibrillation, coronary artery disease, myocarditis, resistant hypertension, atrial and ventricular tachyarrhythmias, pulseless electrical activity, and refractory angina. Elsevier 2017 2017-10-18 /pmc/articles/PMC5650563/ /pubmed/29054204 http://dx.doi.org/10.1016/j.ihj.2017.10.001 Text en © 2017 Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. on behalf of Cardiological Society of India. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Le Voyageur Temp
Mishra, Sundeep
Electroceuticals in medicine – The brave new future
title Electroceuticals in medicine – The brave new future
title_full Electroceuticals in medicine – The brave new future
title_fullStr Electroceuticals in medicine – The brave new future
title_full_unstemmed Electroceuticals in medicine – The brave new future
title_short Electroceuticals in medicine – The brave new future
title_sort electroceuticals in medicine – the brave new future
topic Le Voyageur Temp
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650563/
https://www.ncbi.nlm.nih.gov/pubmed/29054204
http://dx.doi.org/10.1016/j.ihj.2017.10.001
work_keys_str_mv AT mishrasundeep electroceuticalsinmedicinethebravenewfuture